Nurosene buys NetraMark, powers mental healthcare with AI

The projected market size of global AI in healthcare will reach US$120.2 billion by 2028

Nurosene buys NetraMark, powers mental healthcare with AI

To provide AI and data-engineered mental health solutions, the health-tech company Nurosene Health Inc. has agreed to purchase pharmatech NetraMark Corp.

Nurosene announced Tuesday that it has signed a non-binding term sheet to acquire all issued and outstanding shares of NetraMark Corp. The proposed purchase price, reported on August 10, is $15 million, payable in cash and common shares.

Nurosene owns the brain health technology, Nuro App. Ontario-based Netramark is a developer of AI and machine learning solutions for pharmaceutical and biotech companies.

With the acquisition of Netramark, Nurosene said it has decided to shift its resources to improve the Nuro app by using Netramark’s data analytics and AI technology.

Dr. Joseph Geraci, PhD, Founder and CEO of Netramark, said in a press release “By building upon the established AI and data-driven techniques of NetraMark's products, we can effectively accelerate Nurosene's mission to improve mental wellness by evaluating and predicting optimal treatments and therapeutic formulations in collaboration with their proprietary mobile application."

By 2028, the projected market size of global AI in healthcare will reach US$120.2 billion.

Ranj Bath, Nurosene CEO, said in a press release, "The size of the market and projected growth of AI in healthcare, leaves no question for Nurosene and the acquisition of NetraMark. The technology NetraMark has developed will position Nurosene to be a key player in this sector.”

Recent articles & video

Vote for Canadian Lawyer's Top Regional Ontario firms

Privacy and access authorities gather in Toronto to address emerging issues

Federal Court limits trademark to dining services, excludes sit-down and take-out offerings

Ontario Court of Appeal denies mother's bid to prevent child's return to Bangladesh

PEI Court of Appeal affirms property transfer to heir did not require subdivision approval

NS Court of Appeal affirms doctors' right to judicial review in dispute with health authority

Most Read Articles

Federal Court overturns study permit denial, citing unreasonable focus on applicant’s career plans

Ontario court rejects child protection agency’s ‘speculation and gossip’, orders child’s return

Pre-hearing request to review law firm's fees in personal injury case is premature: BC Supreme Court

SK Court of King’s Bench dismisses personal injury claim due to inordinate delay